Globus Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Globus Medical and other ETFs, options, and stocks.

About GMED

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. It engages in developing products that promote healing in patients with musculoskeletal disorders. 

CEO
Keith W. Pfeil
CEOKeith W. Pfeil
Employees
6,000
Employees6,000
Headquarters
Audubon, Pennsylvania
HeadquartersAudubon, Pennsylvania
Founded
2003
Founded2003
Employees
6,000
Employees6,000

GMED Key Statistics

Market cap
9.95B
Market cap9.95B
Price-Earnings ratio
18.96
Price-Earnings ratio18.96
Dividend yield
Dividend yield
Average volume
1.56M
Average volume1.56M
High today
$75.02
High today$75.02
Low today
$73.68
Low today$73.68
Open price
$73.70
Open price$73.70
Volume
2.90M
Volume2.90M
52 Week high
$101.40
52 Week high$101.40
52 Week low
$54.15
52 Week low$54.15

Stock Snapshot

As of today, Globus Medical(GMED) shares are valued at $74.08. The company's market cap stands at 9.95B, with a P/E ratio of 18.96.

On 2026-09-18, Globus Medical(GMED) stock moved within a range of $73.68 to $75.02. With shares now at $74.08, the stock is trading +0.5% above its intraday low and -1.2% below the session's peak.

Trading volume for Globus Medical(GMED) stock has reached 2.9M, versus its average volume of 1.56M.

Over the past 52 weeks, Globus Medical(GMED) stock has traded between a high of $101.40 and a low of $54.15.

Over the past 52 weeks, Globus Medical(GMED) stock has traded between a high of $101.40 and a low of $54.15.

GMED News

TipRanks 2d
Insider Move at Globus Medical: Director Executes Major Stock Sale

New insider activity at Globus Medical ( (GMED) ) has taken place on September 16, 2026. Globus Medical director James Tobin has recently offloaded a significan...

Simply Wall St 3d
Did Imaging Approval Just Shift Globus Medical Stock Investment Narrative?

Globus Medical recently secured CE mark approval for its Excelsius3D imaging system in the EU and UK, expanding its enabling technologies portfolio into new reg...

Did Imaging Approval Just Shift Globus Medical Stock Investment Narrative?

Analyst ratings

65%

of 17 ratings
Buy
64.7%
Hold
35.3%
Sell
0%

People also own

Based on the portfolios of people who own GMED. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.